|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.10 USD | +0.23% |
|
+15.48% | +293.98% |
Chart calendar Magenta Therapeutics
Upcoming events on Magenta Therapeutics
No events available
Past events on Magenta Therapeutics
| 2023-05-03 | Magenta Therapeutics and Dianthus Therapeutics Merger Call |
| 2022-12-13 | American Society of Hematology Meeting |
| 2022-12-12 | American Society of Hematology Meeting - The Pharmacokinetic and Pharmacodynamic |
| 2022-12-12 | American Society of Hematology Meeting - A Phase 2 Open-Label Study |
| 2022-12-12 | American Society of Hematology Meeting - Antibody-Drug Conjugated with Amanitin |
| 2022-12-11 | American Society of Hematology Meeting - Targeted Deletion of Activated |
| 2022-11-08 | Credit Suisse Healthcare Conference |
| 2022-11-03 | Q3 2022 Earnings Release |
| 2022-08-09 | Wedbush PacGrow Healthcare Conference - Panel |
| 2022-08-07 | BTIG Biotechnology Conference |
| 2022-08-04 | Interim 2022 Earnings Release |
| 2022-06-28 | Annual General Meeting |
| 2022-05-16 | Q1 2022 Earnings Release |
| 2022-04-25 | Transplantation & Cellular Therapy Meeting |
| 2022-03-21 | European Society of Blood and Marrow Transplantation Conference - Poster No: P688 |
| 2022-03-21 | European Society of Blood and Marrow Transplantation Conference - Poster No: P689 |
| 2022-03-09 | Cowen & Co. Health Care Conference - Panel |
| 2022-03-08 | FY 2021 Earnings Release |
| 2022-01-28 | B. Riley Securities Virtual Oncology Conference |
| 2022-01-13 | J.P. Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -76,7 -79,8 3.81% | -72,7 -72,9 0.38% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -78,7 -79,5 1.06% | -74,7 -74,3 -0.51% | -80,9 -76,1 -6.32% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -74,9 -76,9 2.59% | -71,1 -71,7 0.84% | -76,5 -73,9 -3.46% |
|
Net income Million USD | Released Forecast Spread | -74,9 -76,2 1.68% | -71,1 -69,9 -1.8% | -76,5 -72,6 -5.25% |
|
EPS USD | Released Forecast Spread | -27,4 -27,8 1.72% | -20,6 -20,2 -2.27% | -20,6 -19,6 -5.16% |
| Announcement Date | 03/03/21 | 08/03/22 | 23/03/23 |
Quarterly results
| Fiscal Period | June | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -19,6 -19,0 -3.18% | -23,3 -18,0 -29.57% | |||||
|
EBIT Million USD | Released Forecast Spread | -20,1 -19,8 -1.53% | -23,8 -19,4 -22.75% | -18,1 -20,7 12.45% | -17,3 -18,1 4.57% | -21,7 -16,9 -28.43% | -32,1 -25,4 -26.37% | -7,38 -11,7 37.19% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,3 -18,9 -2.03% | -23,0 -18,7 -22.7% | -17,3 -19,2 10.16% | -16,1 -17,8 9.6% | -20,2 -17,6 -14.53% | -29,2 -24,9 -17.05% | -3,28 -11,4 71.14% |
|
Net income Million USD | Released Forecast Spread | -19,3 -19,0 -1.76% | -23,0 -19,3 -18.77% | -17,3 -20,5 15.74% | -16,1 -17,8 9.6% | -20,2 -16,4 -23.31% | -29,2 -24,9 -17.05% | -3,28 -11,4 71.14% |
|
EPS USD | Released Forecast Spread | -5,12 -5,15 0.6% | -6,24 -5,31 -17.46% | -4,64 -5,60 17.14% | -4,32 -4,85 10.99% | -5,44 -4,32 -25.93% | -7,68 -6,56 -17.07% | -0,80 -3,04 73.68% |
| Announcement Date | 08/03/22 | 16/05/22 | 04/08/22 | 03/11/22 | 23/03/23 | 15/05/23 | 03/08/23 |
Past sector events for Magenta Therapeutics
- Stock Market
- Equities
- MGTA Stock
- Calendar Magenta Therapeutics
Select your edition
All financial news and data tailored to specific country editions
